E1A-Based Determinants of Oncogenicity in Human Adenovirus Groups A and C

  • J. F. Williams
  • Y. Zhang
  • M. A. Williams
  • S. Hou
  • D. Kushner
  • R. P. Ricciardi
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 273)


A broad spectrum of genetic and molecular investigations carried out with group C, Ad2 and Ad5, and with group A, Ad12, have shown that early regionl (El) gene products are sufficient for complete transformation of rodent cells in vitro by these viruses. During the past quarter century, the processes by which E1A proteins, in cooperation with E1B proteins, perturb the cell cycle and induce the transformed phenotype, have become well defined. Somewhat less understood is the basis for the differential oncogenicity of these two groups of viruses, and the processes by which the E1A proteins of Ad12 induce a tumorigenic phenotype in transformants resulting from infection of cells in vivo and in vitro. In this chapter we review previous findings and present new evidence which demonstrates that Ad12 E1A possesses two or more independent functions enabling it to induce tumors. One of these functions lies in its capacity to repress transcription of MHC class I genes, allowing the tumor cells to avoid lysis by cytotoxic T lymphocytes. We have shown that class I repression is mediated through increased binding of repressor COUP-TF and decreased binding of NF-kB to the class I enhancer. In addition to mediating immune escape, DA also determines the susceptibility of transformants to Natural Killer (NK) cell lysis, and in this case, also, Ad12 transformants are not susceptible. By using Ad 12 mutants containing chimeric E1A Ad12-Ad5 genes, point mutations, or a specific deletion, we have shown that the unique spacer region of Ad12 E1A is an oncogenic determinant, but is not required for transformation in vitro. Given that the E1A regions responsible for class I repression are first exon encoded, we have examined a set of cell lines transformed by these altered viruses, and have found that while they display greatly reduced tumorigenicity, they maintain a wild-type capacity to repress class I transcription. Whether the spacer contributes to NK evasion remains unresolved. Lastly, we discuss the properties of the Ad2/Ad5 E1A C-terminal negative modulator of tumorigenicity, and examine the effects on transformation, tumor induction and transformant tumorigenicity, when the Ad5 negative modulator is placed by chimeric construction in Ad12 E1A.


Major Histocompatibility Complex Class Adenovirus Type Human Adenovirus Chimeric Virus Ad12 Spacer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ackrill AM, Blair GE (1988) Regulation of major histocompatibility class I gene expression at the level of transcription in highly oncogenic adenovirus transformed rat cells. Oncogene 3: 483–487PubMedGoogle Scholar
  2. Bayley ST, Mymryk JS (1994) Adenovirus E1A proteins and transformation (Review). Int J Oncol 5: 425 444Google Scholar
  3. Bernards R, Houweling A, Schrier PI, Bos JL, van der Eb AJ (1982) Characterization of cells transformed by Ad5/Ad12 hybrid early region I plasmids. Virology 120: 422–432PubMedCrossRefGoogle Scholar
  4. Bernards R, Schrier PI, Houweling A, Bos JL, van der Eb AJ, Zylstra M, Melief CJM (1983) Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity. Nature (London) 350: 776–779CrossRefGoogle Scholar
  5. Bernards R, de Leeuw M, Vaessen MJ, van der Eb AJ (1984) Oncogenicity by adeno-virus is not determined by the transforming region only. J Virol 50: 847–853PubMedGoogle Scholar
  6. Boulanger PA, Blair GE (1991) Expression and interactions of human adenovirus oncoproteins. Biochem J 275: 281–299PubMedGoogle Scholar
  7. Boyd JM, Subramanian T, Schaeper U, La Regina M, Bayley S, Chinnadurai G (1993) A region in the C-terminus of adenovirus 2/5 E1A protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J 12: 469–478PubMedGoogle Scholar
  8. Boyer TG, Martin ME, Lees E, Ricciardi RP, Berk AJ, (1999) Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein. Nature 399: 276–279.PubMedCrossRefGoogle Scholar
  9. Byrd PJ, Grand RJA, Breiding D, Williams J, Gallimore PH (1988) Host range mutants of adenovirus type 12 El defective for lytic infection, transformation and oncogenicity. Virology 163: 155–165PubMedCrossRefGoogle Scholar
  10. Chadwick BS, Sambhara SR, Sasakura Y, Miller RG (1992) Effect of class I MHC binding peptides on recognition by natural killer cells. J Immunol 149: 3150–3156PubMedGoogle Scholar
  11. Chan V-L, Smith M (1984) In vitro generation of specific deletions in DNA cloned in M13 vectors using synthetic oligodeoxyribonucleotides: mutants in the 5’-flanking region of the yeast alcohol dehydrogenase II gene. Nucleic Acids Res. 12: 2407–2419.PubMedCrossRefGoogle Scholar
  12. Cook JL, Hibbs Jr JB, Lewis Jr. AM (1982) DNA virus-transformed hamster cell-host effector cell interactions: level of resistance to cytolysis correlated with tumorigenicity. Int J Cancer 30: 795–803PubMedCrossRefGoogle Scholar
  13. Cook JL, May DL Wilson BA Holskin B Chen MJ Shalloway D, Walker TA (1989) Role of tumor necrosis factor-alpha in ETA oncogene-induced susceptibility of neoplastic cells to lysis by natural killer cells and activated macrophages. J Immunol 142: 4527–4534Google Scholar
  14. Douglas JL, Gopalakrishnan S, Quinlan MP (1991) Modulation of transformation of primary epithelial cells by the second exon of the Ad5 E1A 12S gene. Oncogene 6: 2093–2103PubMedGoogle Scholar
  15. Eager KB, Williams J, Breiding D, Pan S, Knowles B, Appela E, Ricciardi RP (1985) Expression of histocompatibility antigens H-2 K, D, and L is reduced in adenovirus-12-transformed mouse cells and is restored by interferon y Proc Natl Acad Sci USA 82: 5525–5529PubMedCrossRefGoogle Scholar
  16. Edbauer D, Lamberti C, Tong J, Williams J (1988) Adenovirus type 12 EIB 19-kilodalton protein is not required for oncogenic transformation in rats. J Virol 62: 3265–3273PubMedGoogle Scholar
  17. Fischer RS, Quinlan MP (1998) Expression of the Rb binding regions of EIA enables efficient transformation of primary epithelial cells by v-src. J. Virol 72: 2815–2824PubMedGoogle Scholar
  18. Fischer RS, Quinlan MP (2000) While E1A can facilitate epithelial cell transformation by several dominant oncogenes, the C-terminus seems only to regulate rac and cdc 42 function, but in both epithelial and fibroblastic cells. (2000) Virology 269: 409–419Google Scholar
  19. Friedman DJ, Ricciardi RP (1988) Adenovirus type 12 E1A gene represses accumulation of MHC class I mRNA at the level of transcription. Virology 165: 303–305PubMedCrossRefGoogle Scholar
  20. Gallimore PH (1972) Tumor production in immunosuppressed rats with cells transformed in vitro by adenovirus type 2. J Gen Virol 16: 99–102PubMedCrossRefGoogle Scholar
  21. Gallimore PH, Williams J (1982) An examination of adenovirus type 5 mutants for their ability to induce group C adenovirus tumor-specific antigenicity in rats. Virology 120: 146–156PubMedCrossRefGoogle Scholar
  22. Gallimore PH, Byrd PJ, Grand RJA (1984a) Adenovirus genes involved in transformation. What determines the oncogenic phenotype?, p. 125–172. In Rigby PWJ, Wilkie NM (ed.), Symposium of the Society for General Microbiology. Viruses and Cancer. Cambridge University Press, CambridgeGoogle Scholar
  23. Gallimore P, Byrd P, Grand R, Whittaker J, Breiding D, Williams J (1984b). An examination of the transforming and tumor-inducing capacity of a number of adenovirus type 12 early region 1, host-range mutants and cells transformed by subgenomic fragments of Ad12 El region. Cancer Cells 2: 519–526Google Scholar
  24. Gallimore PH, Williams J, Breiding D, Grand RJA, Rowe M., Byrd P (1986) Studies on adenovirus type-12 El region: gene expression, transformation of human and rodent cells, and malignancy. Cancer Cells 4: 339–348Google Scholar
  25. Ge R, Kralli A, Weinmann R, Ricciardi RP. (1992) Down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells is accompanied by an increase in factor binding. J.Virol. 66: 6969–6978PubMedGoogle Scholar
  26. Ge R, Liu X, Ricciardi RP (1994) EIA oncogene of adenovirus-12 mediates trans-repression of MHC class I transcription in Ad5/Ad12 somatic hybrid transformed cells. Virology. 203: 389–392PubMedCrossRefGoogle Scholar
  27. Graham FL, Harrison T, Williams J (1978) Defective transforming capacity of adenovirus type 5 host-range mutants. Virology 86: 10–21PubMedCrossRefGoogle Scholar
  28. Graham FL (1984) Transformation by and oncogenicity of human adenoviruses, p 339–398. In Ginsberg HS (ed.), The adenoviruses. Plenum Press, New YorkCrossRefGoogle Scholar
  29. Haddada H, Lewis Jr AM, Sogn JA, Coligan JE, Cook JL, Walker TA, Levine AS (1986) Tumorigenicity of hamster and mouse cells transformed by adenovirus types 2 and 5 is not influenced by the level of class I major histocompatibility antigens expressed on the cells. J Virol 83: 9684–9688Google Scholar
  30. Haddada H, Sogn JA, Coligan JE, Carbone M, Dixon K, Levine AS, Lewis, Jr, AM (1988) Viral gene inhibition of class I major histocompatibility antigen expression: not a general mechanism governing the tumorigenicity of adenovirus type 2-, adenovirus type 12-, and simian virus 40-transformed Syrian hamster cells. J Virol 2755–2761Google Scholar
  31. Hayashi H, Tanaka K, Jay F, Khoury G, Jay G (1985) Modulation of the tumorigenici- ty of human adenovirus-12-transformed cells by interferon. Cell. 43: 263–267PubMedCrossRefGoogle Scholar
  32. Houweling A, Van den Elsen PJ, van der Eb AJ (1980) Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA. Virology 105: 537–550PubMedCrossRefGoogle Scholar
  33. Huebner RJ, Rowe WP, Lane WT (1962) Oncogenic effects in hamsters of human adenovirus types 12 and 18. Proc Natl Acad Sci USA 48: 2051–2058PubMedCrossRefGoogle Scholar
  34. Huvent I, Cousin C, Kiss A, Bernard C, D’Halluin JC (1996) Susceptibility to natural killer cells and down regulation of MHC class I expression in adenovirus 12 transformed cells are regulated by different E1A domains. Virus Res 45: 123–134PubMedCrossRefGoogle Scholar
  35. Javier RT, Raska K Jr, Shenk T (1992) Requirement for the adenovirus type 9 E4 region in production of mammary tumors. Science 257: 1267–1271PubMedCrossRefGoogle Scholar
  36. Javier RT (1994) Adenovirus type 9 E4 open reading frame 1 encodes a transforming protein required for the production of mammary tumors in rats. J Virol 68: 3917–3924PubMedGoogle Scholar
  37. Jelinek T, Pereira DS, Graham FL (1994) Tumorigenicity of adenovirus-transformed rodent cells is influenced by at least two regions of adenovirus type 12 early region 1A. J Virol 68: 888–896PubMedGoogle Scholar
  38. Jones NC (1992) The multifunctional products of the adenovirus E1A gene, p. 87113. In Doerfler W, Böhm P (ed), Malignant transformation by DNA viruses. VCH Publishers, Weinheim, GermanyGoogle Scholar
  39. Jonsson N, Ankerst J (1977) Studies on adenovirus type 9-induced mammary fi- broadenomas in rats and their malignant transformation. Cancer 39: 2513–2519PubMedCrossRefGoogle Scholar
  40. Kärre K, Ljunggren HG, Pointek G, Kiessling R (1986) Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defense strategy. Nature 319: 675–678PubMedCrossRefGoogle Scholar
  41. Kast WM, Offringa R, Peters PJ, Voordouw AC, Meloen RH, van der Eb AJ, Melief CJM (1989) Eradication of adenovirus El-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell 59: 603–614PubMedCrossRefGoogle Scholar
  42. Kenyon DJ, Raska K Jr (1986) Region Ela of highly oncogenic adenovirus 12 in transformed cells protects against NK but not LAK cytolysis. Virology. 155: 644–654PubMedCrossRefGoogle Scholar
  43. Kimelmann D, Miller JS, Porter D, Roberts BE (1985) EIA regions of the human adenoviruses and of the highly oncogenic simian adenovirus 7 are closely related. J Virol 53: 399–409Google Scholar
  44. Kralli A, Ge R, Graeven U, Ricciardi RP (1992) Weinmann R. Negative regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells via a retinoic acid response element. J.Virol. 66: 6979–6988PubMedGoogle Scholar
  45. Krantz CK, Routes BA, Quinlan MP, Cook JL (1996) EIA second exon requirements for induction of target cell susceptibility to lysis by natural killer cells: implications for the mechanism of action. Virology 217: 23–32PubMedCrossRefGoogle Scholar
  46. Kunkel TA (1985) Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 82: 488–492PubMedCrossRefGoogle Scholar
  47. Kushner DB, Pereira DS, Liu X, Graham FL, Ricciardi RP (1996) The first exon of Ad12 E1A excluding the transactivation domain mediates differential binding of COUP-TF and NF-KB to the MHC class I enhancer in transformed cells. Oncogene 12: 143–151PubMedGoogle Scholar
  48. Kushner DB, Ricciardi RP (1999) Reduced phosphorylation of p50 is responsible for diminished NF-KB binding to the major histocompatibility complex class I enhancer in adenovirus 12 transformed cells. Mol Cell Biol 99: 2169–2179Google Scholar
  49. Lamberti C, Williams J (1990) Differential requirement for adenovirus type 12 E1A gene products in oncogenic transformation. J Virol 64: 4997–5007PubMedGoogle Scholar
  50. Lanier LL (2000) The origin and functions of natural killer cells. Clin Immunol. 95: S14–18.PubMedCrossRefGoogle Scholar
  51. Review Larsen PL, Tibbetts C (1987) Adenovirus DA gene autorepression: revertants of an E1A promoter mutation encode altered E1A proteins. Proc Natl Acad Sci USA 84: 8185–8189CrossRefGoogle Scholar
  52. Lewis Jr, AM, Cook JL (1982) Spectrum of tumorigenic phenotypes among adenovirus 2, adenovirus 12 and simian virus 40 transformed Syrian hamster cells defined by host cellular immune-tumor cell interactions. Cancer Res 42: 939–944PubMedGoogle Scholar
  53. Licht JD, Grossel MU, Figge J, Hansen UM (1990) Drosophila Krüppel protein is a transcriptional repressor. Nature (London) 346: 76–79CrossRefGoogle Scholar
  54. Liu X, Ge R, Ricciardi RP (1996) Evidence for the involvement of a nuclear NF-KB inhibitor in global down-regulation of the major histocompatibility complex class I enhancer in adenovirus typel2-transformed cells. Mol Cell Biol 16: 398–404PubMedGoogle Scholar
  55. Lyons RH, Ferguson BQ, Rosenberg M (1987) pentapeptide nuclear localization signal in adenovirus EIA. Mol Cel Biol 7: 2451–2456Google Scholar
  56. Mayo MW, Baldwin AS (2000) The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta1470: 55–62.Google Scholar
  57. Review Mautner V, Steinthorsdottir V, Bailey A (1995) Enteric adenoviruses. Curr Top Microbiol Immunol 199/II 229–282Google Scholar
  58. McLorie W, McGlade CJ, Takayesu D, Branton PE (1991) Individual adenovirus EIB proteins induce transformation independently but by additive pathways. J Gen Virol 72: 1467–1471PubMedCrossRefGoogle Scholar
  59. Mellow GH, Föhring B, Dougherty J, Gallimore PH, Raska K (1984) Tumorigenicity of adenovirus-transformed rat cells and expression of class I major histocompatibility antigen. Virology 134: 951–961CrossRefGoogle Scholar
  60. Miller BW, Williams J (1987) Cellular transformation by adenovirus type 5 is influenced by the viral DNA polymerase. J Virol 61, 11: 3630–3634PubMedGoogle Scholar
  61. Molloy DP, Milner AE, Yakub IK, Chinnadurai G, Gallimore PH, Grand RJA (1998) Structural determinants present in the C-terminal binding protein binding site of adenovirus early region lA proteins. J Biol Chem 273: 20867–20876PubMedCrossRefGoogle Scholar
  62. Molloy DP, Barral PM, Bremmner KH, Gallimore PH, Grand RJA (2001) Structural determinants outside the PXDLS sequence affect the interaction of adenovirus E1A, C-terminal interacting protein and Drosophila repressors with C-terminal binding protein. Biochim Biophys Acta 1546: 55–70Google Scholar
  63. Montell C, Courtois G, Eng C, Berk A (1984) Complete transformation by adenovirus 2 requires both EIA proteins. Cell 36: 951–961PubMedCrossRefGoogle Scholar
  64. Moran E, Grodzicker T, Roberts RJ, Mathews MB, Zerler B. (1986) Lytic and transforming functions of individual products of the adenovirus E1A gene. J Virol 57: 765–775PubMedGoogle Scholar
  65. Nibu & Zhang H, Levine M (1998) Interaction of short-range repressors with Drosophila CtBP in the embryo. Science 280: 101–104Google Scholar
  66. Nielsch U, Zimmer SG, Babiss LE (1991) Changes in NF-kappa B and ISGF3 DNA binding activities are responsible for differences in MHC and beta-IFN gene expression in Ads-versus Ad12-transformed cells. EMBO J 10: 4169–4175PubMedGoogle Scholar
  67. Pääbo S, Severinsson L., Andersson M, Martens I, Nilsson T, Peterson PA (1989) Adenovirus proteins and MHC expression. Adv Cancer Res 52: 151–163PubMedCrossRefGoogle Scholar
  68. Poortinga G, Watanabe M, Parkhurst SM (1998) Drosophila CtBP: A hairy-interacting protein required for embryonic segmentation and hairy-mediated transcriptional repression. EMBO J 17: 2067–2078Google Scholar
  69. Pointek GE, Tanignchi K, Ljunggren HG, Grönberg A, Kiessling R, Klein G, Kärre K (1985) YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment of in vivo passage. J Immunol 135: 4281–4288Google Scholar
  70. Quinlan MP, Douglas JL (1992) Immortalization of primary epithelial cells requires first and second exon functions of adenovirus type 5 12S. J. Virol 66: 2020–2030PubMedGoogle Scholar
  71. Raska K Jr, Gallimore PH (1982) An inverse relation of the oncogenic potential of adenovirus-transformed cells and their sensitivity to killing by syngeneic natural killer cells. Virology 123: 8–18PubMedCrossRefGoogle Scholar
  72. Raska K Jr (1995) Functional domains of adenovirus E1A oncogenes which control interactions with effectors of cellular immunity. Curr Top Microbiol Immunol 199: 131–148PubMedCrossRefGoogle Scholar
  73. Ricciardi RP. (1999) Adenovirus transformation and tumorigenicity In: Seth P (ed) Adenoviruses: Basic biology to gene therapy. Austin: RG Landes Co. 217–227.Google Scholar
  74. Rice SA, Klessig DF, Williams J (1987) Multiple effects of the 72-kDa, adenovirusspecified DNA binding protein on the efficiency of cellular transformation. Virology 156: 366–376PubMedCrossRefGoogle Scholar
  75. Roberts BE, Miller JS, Kimelmann D, Cepko CL, Lemischka IR, Mulligan RC (1985) Individual adenovirus type 5 early region lA gene products elicit distinct alterations of cellular morphology and gene expression. J Virol 56: 404–413PubMedGoogle Scholar
  76. Routes JM, Bellgrau D, McGrory WJ, Bautista DS, Graham FL, Cook JL (1991) Antiadenovirus type 5 cytotoxic T lymphocytes: immunodominant epitopes are encoded by the E1A gene. J Virol 65: 1450–1457PubMedGoogle Scholar
  77. Ruley HE (1983) Adenovirus early region lA enables viral and cellular transforming genes to transform primary cells in culture. Nature (London) 304: 602–606CrossRefGoogle Scholar
  78. Rumpf H, Esche H, Kirch H-C (1999) Two domains within the adenovirus type 12 E1A unique spacer have disparate effects on the interaction of E1A with p105Rb and the transformation of primary mouse cells. Virology 257: 45–53PubMedCrossRefGoogle Scholar
  79. Sawada Y, Föhring B, Shenk T, Raska K Jr (1985) Tumorigenicity of adenovirus transformed cells: region E1A of adenovirus 12 confers resistance to natural killer cells Virology 147: 413–421Google Scholar
  80. Sawada Y, Urbanelli D, Raskova J, Shenk T, Raska K Jr (1986) Adenovirus tumor-specific transplantation antigen is a function of the E1A early region. J Exp Med 163: 563–572PubMedCrossRefGoogle Scholar
  81. Sawada Y, Raska K Jr, Shenk T (1988) Adenovirus type 5 and type 12 recombinant viruses containing heterologous El genes are viable, transform rat cells, but are not tumorigenic in rats. Virology 166: 281–284PubMedCrossRefGoogle Scholar
  82. Sawada Y, Raskova J, Fujinaga K, Raska K Jr (1994) Identification of functional domains of adenovirus tumor-specific transplantation antigen in types 5 and 12 by viable viruses carrying chimeric E1A genes. Int J. Cancer 57: 598–603Google Scholar
  83. Schaeper U, Boyd JM, Verma S, Uhlmann E, Subramanian T, Chinnadurai G (1995) Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci 92: 10467–10471PubMedCrossRefGoogle Scholar
  84. Schaeper U, Subramanian T, Lim L, Boyd JM, Chinnadurai G (1998) Interaction between a cellular protein that binds to the C-terminal region of adenovirus E1A (CtBP) and a novel cellular protein is disrupted by E1A through a conserved PLDLS motif. J Biol Chem 273: 8549–8552Google Scholar
  85. Schrier PI, Bernards R, Vaessen RTMJ, Houweling A, van der Eb AJ (1983) Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature (London) 305: 771–775CrossRefGoogle Scholar
  86. Scott MO, Kimelman D, Norris D, Ricciardi RP (1984) Production of a monospecific antisera against the E1A protein of Ad12 and Ad5 by an Ad12 E1A/ß-galactosidase fusion protein expressed in bacteria. J. Virol. 50: 895–903PubMedGoogle Scholar
  87. Shiroki K, Segawa K, Saito I, Shimojo H, Fujinaga K (1979) Products of the adenovirus 12 transforming genes and their functions. Cold Spring Harbor Symp Quant Biol 44: 533–540CrossRefGoogle Scholar
  88. Shiroki K, Hashimoto S, Saito I, Fukui Y, Fukui Y, Hiroyuki K, Shimojo H (1984) Expression of the E4 gene is required for establishment of soft-agar colony-forming rat cell lines transformed by the adenovirus 12 El gene. J Virol 50, 3: 854–863PubMedGoogle Scholar
  89. Sjögren HO, Minowada J, Ankerst J (1968) Specific transplantation antigens of mouse sarcomas induced by adenovirus type 12. J Exp Med 125: 689–701CrossRefGoogle Scholar
  90. Smirnov DA, Hou S, Ricciardi RP. (2000) Association of histone deacetylase with COUP-TF in tumorigenic Ad12 transformed cells and its potential role in shut-off of MHC class I transcription. Virology 268: 319–328PubMedCrossRefGoogle Scholar
  91. Smirnov DA, Hou S, Liu X, Claudio E, Siebenlist UK, Ricciardi RP (2001). COUPTFII is up-regulated in adenovirus type 12 tumorigenic cells and is a repressor of MHC class I transcription. Virology 284: 13–19PubMedCrossRefGoogle Scholar
  92. Soddu S, Lewis Jr AM (1992) Driving adenovirus type 12-transformed BALB/c mouse cells to express high levels of class I major histocompatibility complex proteins enhances, rather than abrogates, their tumorigenicity. J Virol 66: 2875–2884PubMedGoogle Scholar
  93. Sollerbrant K, Chinnadurai G, Svensson K (1996) The CtBP binding domain in the adenovirus MA protein controls CR1-dependent transactivation. Nucleic Acids Res 24: 2578–2584Google Scholar
  94. Storkus WJ, Salter RD, Cresswell P, Dawson JR (1992) Peptide-induced modulation of target cell sensitivity to natural killing. J Immunol 149: 1185–1190PubMedGoogle Scholar
  95. Subramanian T, Malstrom SE, Chinnadurai G (1991) Requirement of the C-terminal region of adenovirus E1A for cell transformation in cooperation with El B. Oncogene 6: 1171–1173PubMedGoogle Scholar
  96. Subramanian T, La Regina M, Chinnadurai G (1989) Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1A protein. Oncogene 4: 415–420PubMedGoogle Scholar
  97. Tanaka K, Isselbacher KJ, Khoury G, Jay G (1985) Reversal of oncogenesis by the expression of a histocompatibility complex class I gene. Science 228: 26–30PubMedCrossRefGoogle Scholar
  98. Telling GC, Williams J (1994) Constructing chimeric type 12/type 5 adenovirus E1A genes and using them to identify an oncogenic determinant of adenovirus type 12. J Virol 68, 2: 877–887PubMedGoogle Scholar
  99. Trentin JJ, Yabe Y, Taylor G (1962) The quest for human cancer viruses. Science 137: 835–841PubMedCrossRefGoogle Scholar
  100. Trentin JJ, Bryan E (1966) Virus induced transplantation immunity to human adenovirus type 12 tumors of the hamster and mouse. Proc Soc Exp Biol Med 121: 1216–1219PubMedGoogle Scholar
  101. Urbanelli D, Sawada Y, Raskova J, Jones NC, Shenk T, Raska K (1989) C-terminal domain of the adenovirus E1A oncogene product is required for induction of cytotoxic T lymphocytes and tumor-specific transplantation immunity. Virology 173: 607–614PubMedCrossRefGoogle Scholar
  102. van der Eb AJ, Mulder C, Graham FL, Houweling A (1977) Transformation with specific fragments of adenovirus DNAs. I. Isolation of specific fragments with transforming activity of adenovirus 2 and 5 DNA. Gene 2: 115–132Google Scholar
  103. van der Eb AJ, Zantema A (1992) Adenovirus oncogenesis. p 115–140. In Doerlfer W, Böhm P. (ed.) Malignant transformation by DNA viruses. VCH Publishers, Weinheim, GermanyGoogle Scholar
  104. van den Elsen PJ, de Pater S, Houweling A, van der Veer J, van der Eb AJ (1982) The relationship between region E1A and E1B of human adenoviruses in cell transformation. Gene 18: 175–185PubMedCrossRefGoogle Scholar
  105. van Ormondt H, Galibert F (1984) Nucleotide sequences of adenovirus DNAs. Curr Top Microbiol Immunol 110: 73–142Google Scholar
  106. Vasavada R, Eager KB, Barbanti-Brodano G, Caputo A, Ricciardi RP. (1986) Adenovirus type 12 early region lA proteins repress class I HLA expression in transformed human cells. Proc. Natl. Acad. Sci. USA 83: 5257–61.Google Scholar
  107. Williams JF, Young CSH, Austin PE (1974) Genetic analysis of human adenovirus type 5 in permissive and nonpermissive cells. Cold Spring Harbor Symp Quant Biol 39: 427–437CrossRefGoogle Scholar
  108. Williams J (1986) Adenovirus genetics, p. 247–309. In Doerfler W (ed.), Adenovirus DNA: the viral genome and its expression. Martinus Nijhoff, The Hague, the Netherlands.CrossRefGoogle Scholar
  109. Williams J (1973) Oncogenic transformation of hamster embryo cells in vitro by adenovirus type 5. Nature 243: 162–163PubMedCrossRefGoogle Scholar
  110. Williams J, Williams M, Liu C, Telling G (1995) Assessing the role of E1A in the differential oncogenicity of group A and group C human adenoviruses. Curr Top Microbiol Immunol 199/II 149–175Google Scholar
  111. Winberg G, Shenk T (1984) Dissection of overlapping functions within the adenovirus type 5 E1A gene. EMBO J 3: 1907–1912PubMedGoogle Scholar
  112. Wold WS, Tollefson AE (1999) Adenovirus-host interactions to subvert host immune system. In: Seth P (ed) Adenoviruses: Basic biology to gene therapy. Austin: RG Landes Co. 245–252Google Scholar
  113. Yewdell JW, Bennink JR, Eager KB, Ricciardi RP. (1988) CTL recognition of adenovirus-transformed cells infected with influenza virus: lysis by anti-influenza CTL parallels adenovirus-12-induced suppression of class I MHC molecules. Virol. 162: 236–238CrossRefGoogle Scholar
  114. Zhou C, Tsai SY, Tsai M. (2000) >From apoptosis to angiogenesis: new insights into the roles of nuclear orphan receptors, chicken ovalbumin upstream promoter-transcription factors, during development. Biochim Biophys Acta 1470:M63–68. ReviewGoogle Scholar
  115. Zinkernagel RM, Doherty PC (1979) MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function and responsiveness. Adv Immunol 27: 51–177PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • J. F. Williams
    • 1
  • Y. Zhang
    • 1
  • M. A. Williams
    • 1
  • S. Hou
    • 2
  • D. Kushner
    • 3
  • R. P. Ricciardi
    • 2
  1. 1.Department of Biological SciencesCarnegie Mellon UniversityPittsburghUSA
  2. 2.Department of Microbiology, School of Dental Medicine, Department of Biochemistry and Molecular BiophysicsUniversity of PennsylvaniaPhiladelphiaUSA
  3. 3.Institute for Molecular VirologyUniversity of WisconsinMadisonUSA

Personalised recommendations